-
14017-50An isothiocyanate derived from cruciferous vegetables that has significant antiapoptotic and antioxidant effects in various cancer cells.
-
17191-1A decomposition product of the macrolide antibiotic, erythromycin A that has been identified as a &beta-turn mimic of the peptide hormone motilin used to determine the binding characteristics of ligands of the motilin receptor.
-
17191-10A decomposition product of the macrolide antibiotic, erythromycin A that has been identified as a &beta-turn mimic of the peptide hormone motilin used to determine the binding characteristics of ligands of the motilin receptor.
-
17191-5A decomposition product of the macrolide antibiotic, erythromycin A that has been identified as a &beta-turn mimic of the peptide hormone motilin used to determine the binding characteristics of ligands of the motilin receptor.
-
17189-1A soluble salt of the macrolide antibiotic suitable for intraperitoneal or intravenous injections.
-
17189-10A soluble salt of the macrolide antibiotic suitable for intraperitoneal or intravenous injections.
-
17189-5A soluble salt of the macrolide antibiotic suitable for intraperitoneal or intravenous injections.
-
17189-500A soluble salt of the macrolide antibiotic suitable for intraperitoneal or intravenous injections.
-
16486-10A macrolide antibiotic that inhibits bacterial protein synthesis by targeting the 50S ribosomal subunit, blocking the progression of nascent polypeptide chains inhibits CYP3A4.
-
16486-100A macrolide antibiotic that inhibits bacterial protein synthesis by targeting the 50S ribosomal subunit, blocking the progression of nascent polypeptide chains inhibits CYP3A4.
-
16486-25A macrolide antibiotic that inhibits bacterial protein synthesis by targeting the 50S ribosomal subunit, blocking the progression of nascent polypeptide chains inhibits CYP3A4.
-
16486-5A macrolide antibiotic that inhibits bacterial protein synthesis by targeting the 50S ribosomal subunit, blocking the progression of nascent polypeptide chains inhibits CYP3A4.